BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 29771808)

  • 1. Predicting Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendix Adenocarcinoma.
    Aziz O; Jaradat I; Chakrabarty B; Selvasekar CR; Fulford PE; Saunders MP; Renehan AG; Wilson MS; O'Dwyer ST
    Dis Colon Rectum; 2018 Jul; 61(7):795-802. PubMed ID: 29771808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal Involvement Is More Common Than Nodal Involvement in Patients With High-Grade Appendix Tumors Who Are Undergoing Prophylactic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Mehta A; Mittal R; Chandrakumaran K; Carr N; Dayal S; Mohamed F; Moran B; Cecil T
    Dis Colon Rectum; 2017 Nov; 60(11):1155-1161. PubMed ID: 28991079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases.
    Ihemelandu C; Mavros MN; Sugarbaker P
    Ann Surg Oncol; 2016 Dec; 23(13):4231-4237. PubMed ID: 27338748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological Subtype Remains a Significant Prognostic Factor for Survival Outcomes in Patients With Appendiceal Mucinous Neoplasm With Peritoneal Dissemination.
    Huang Y; Alzahrani NA; Chua TC; Morris DL
    Dis Colon Rectum; 2017 Apr; 60(4):360-367. PubMed ID: 28267002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should a History of Extraperitoneal Disease Be a Contraindication to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases?
    Baratti D; Kusamura S; Iusco D; Cotsoglou C; Guaglio M; Battaglia L; Virzì S; Mazzaferro V; Deraco M
    Dis Colon Rectum; 2018 Sep; 61(9):1026-1034. PubMed ID: 30086051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Prognostic Model for Predicting Overall Survival in Patients with Peritoneal Surface Malignancy of an Appendiceal Origin Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Ihemelandu C; Fernandez S; Sugarbaker PH
    Ann Surg Oncol; 2017 Aug; 24(8):2266-2272. PubMed ID: 28342015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence and Survival Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Small Bowel Adenocarcinoma.
    Saxena A; Valle SJ; Liauw W; Morris DL
    Anticancer Res; 2017 Oct; 37(10):5737-5742. PubMed ID: 28982894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
    Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prior Surgical Score: An Analysis of the Prognostic Significance of an Initial Nondefinitive Surgical Intervention in Patients With Peritoneal Carcinomatosis of a Colorectal Origin Undergoing Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy.
    Paul BK; Ihemelandu C; Sugarbaker PH
    Dis Colon Rectum; 2018 Mar; 61(3):347-354. PubMed ID: 29420428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicystic mesothelioma: Operative and long-term outcomes with cytoreductive surgery and hyperthermic intra peritoneal chemotherapy.
    Nizri E; Baratti D; Guaglio M; Sinukumar S; Cabras A; Kusamura S; Deraco M
    Eur J Surg Oncol; 2018 Jul; 44(7):1100-1104. PubMed ID: 29703622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours.
    Lord AC; Shihab O; Chandrakumaran K; Mohamed F; Cecil TD; Moran BJ
    Eur J Surg Oncol; 2015 Mar; 41(3):396-9. PubMed ID: 25216980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: an emerging treatment option for advanced goblet cell tumors of the appendix.
    McConnell YJ; Mack LA; Gui X; Carr NJ; Sideris L; Temple WJ; Dubé P; Chandrakumaran K; Moran BJ; Cecil TD
    Ann Surg Oncol; 2014 Jun; 21(6):1975-82. PubMed ID: 24398544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis secondary to mucinous adenocarcinoma of the appendix.
    Sparks DS; Morris B; Xu W; Fulton J; Atkinson V; Meade B; Lutton N
    Int Surg; 2015 Jan; 100(1):21-8. PubMed ID: 25594636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Ovarian Involvement in Advanced Colorectal or Appendiceal Tumors Involving the Peritoneum.
    Mehta AM; Bignell MB; Alves S; Dayal SP; Mohamed F; Cecil TD; Moran BJ
    Dis Colon Rectum; 2017 Jul; 60(7):691-696. PubMed ID: 28594718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of Systemic Chemotherapy in Patients With Colorectal Peritoneal Carcinomatosis Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    van Eden WJ; Kok NF; Jóźwiak K; Lahaye ML; Beets GL; van Leerdam ME; Boot H; Aalbers AG
    Dis Colon Rectum; 2017 May; 60(5):477-487. PubMed ID: 28383447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Jimenez W; Sardi A; Nieroda C; Sittig M; Milovanov V; Nunez M; Aydin N; Gushchin V
    Ann Surg Oncol; 2014 Dec; 21(13):4218-25. PubMed ID: 24986239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours.
    Ansari N; Chandrakumaran K; Dayal S; Mohamed F; Cecil TD; Moran BJ
    Eur J Surg Oncol; 2016 Jul; 42(7):1035-41. PubMed ID: 27132072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction.
    Klaver YL; Chua TC; Verwaal VJ; de Hingh IH; Morris DL
    J Surg Oncol; 2013 May; 107(6):585-90. PubMed ID: 23280508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged Survival in Peritoneal Metastatic Appendiceal Carcinoma Patients Treated With Combined Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Acs M; Gerken M; Zustin J; Blaj S; Isgandarova S; Piso P
    J Surg Res; 2023 Mar; 283():839-852. PubMed ID: 36915011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
    Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
    Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.